Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,637,670
+$5,334,117 QoQ
Shares Held
1,425,546
+11.3% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#74
of 1,020 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $28,794,500 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (78.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
1,425,546 | $22,637,670 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
206,900 | $3,316,607 | |
| 3 | HLN |
Haleon plc
|
300,561 | $2,804,234 | |
| 4 | ZTS |
Zoetis Inc.
|
239 | $17,174 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
55 | $9,269 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
7 | $3,792 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
86 | $2,913 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38 | $1,767 |
All Filings in VTRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,637,670 | 1,425,546 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,303,553 | 1,280,796 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $17,430,000 | 1,400,000 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,504,000 | 960,000 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $8,573,130 | 960,037 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,453,608 | 855,753 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $9,685,240 | 777,931 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $9,755,151 | 840,237 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $9,706,497 | 913,123 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||